NOLAND HOSPITAL BIRMINGHAM II — History
CCN 012009 | 3-year financial timeline | COVID resilience: 53/100
🛡️ Public data only — no PHI permitted on this instance.
$12M
Latest Revenue (FY2022)
+2.5%
Revenue CAGR (3yr)
-0.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $11M | $11M | $12M | +3.6% | +2.5% |
| Operating Expenses | $8M | $11M | $12M | +5.5% | +18.7% |
| Operating Margin | 25.2% | 1.5% | -0.3% | -120.8% | +0.0% |
| Net Income | $3M | $0M | $-0M | -121.5% | +0.0% |
| Licensed Beds | 45 | 79 | 79 | +0.0% | +32.5% |
| Total Patient Days | 6,806 | 7,933 | 8,110 | +2.2% | +9.2% |
| Medicare Day % | 49% | 37% | 35% | -5.1% | -15.1% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 53/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +5.1% ($11M → $12M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+2.5%
This Hospital
+7.6%
State Avg
Latest Margin
-0.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $12M | -13.1% |
| FY2024 (proj) | $12M | -25.8% |
| FY2025 (proj) | $12M | -38.6% |